发明名称 ANTI-CANCER COMPOUNDS
摘要 Provided are methods and compositions for the treatment of diseases such as cancer. In certain aspects, compounds which can inhibit Skp2 are provided. Specifically chromenone derivatives are disclosed that have the capability toward reducing differentiation of pluripotent, multipotent or totipotent cells and thus have therapeutic utility in the treatment of a proliferative disease such as cancer.
申请公布号 US2016145250(A1) 申请公布日期 2016.05.26
申请号 US201414905726 申请日期 2014.07.18
申请人 BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 发明人 ZHANG Shuxing;LIN Hui-Kuan;CHAN Chia-Hsin;MORROW John Kenneth
分类号 C07D417/14;A61K31/428;A61K45/06;A61K31/4184;A61K31/423;A61K31/55;A61K31/454;A61K31/5377 主分类号 C07D417/14
代理机构 代理人
主权项 1. A method of treating a hyperproliferative disease, comprising administering to a subject an effective amount of a compound having the structure: wherein R1 is heteroaryl(C≦18) or substituted heteroaryl(C≦18); R2, R3, R4, R5, R7, R8, R9, and R10 are each independently selected from the group consisting of hydrogen, alkyl(C≦18), substituted alkyl(C≦18); heteroaryl(C≦18), substituted heteroaryl(C≦18), heterocycloalkyl(C≦18), substituted heterocycloalkyl(C≦18), acyl(C≦18), C(O)O-alkyl(C≦18), -alkyl(C≦12)-heterocycloalkyl(C≦18), aryl(C≦18), OH, —SH, CF3, X1 and X2 are each independently hydrogen, substituted alkyl(C1-12), or alkyl(C1-12); X3 is alkyl(C≦12) or substituted alkyl(C≦12); Y1 is —H, aryl(C≦18), or heteroaryl(C≦18); and R6 is selected from the group consisting of —H, alkyl(C≦18), —NH2, C(O)Oalkyl(C≦18), and substituted alkyl(C≦18); R11 is -alkyl(C≦6)-heterocycloalkyl(C≦18) or -alkyl(C≦6)-substituted heterocycloalkyl(C≦18); or a pharmaceutically acceptable salt or tautomer thereof.
地址 Austin TX US